New bipartisan legislation seeks to prevent health insurers from owning pharmacies, targeting the monopolistic power of pharmacy benefit managers.
If enacted, this legislation could disrupt the current healthcare market dominated by a few conglomerates. The effort highlights ongoing concerns about drug pricing and transparency.